Orion Corporation
Senior Biostatistician, Biostatistics, R&D, Orion Corporation
You will join a growing oncology-focused Data Sciences function and provide statistical support across Phase I–III oncology studies within our expanding portfolio. The Senior Biostatistician contributes to the design, analysis, interpretation, and reporting of oncology clinical trials and serves as a key statistical contributor for assigned studies throughout the clinical development lifecycle.
With a particular focus on biomarker, translational, and precision medicine analyses, the Senior Biostatistician collaborates closely with Clinical Development, Translational Medicine, Data Sciences, Statistical Programming, and external partners to deliver high-quality statistical solutions throughout the drug development lifecycle.
Responsibilities
- Contribute to the design and statistical aspects of clinical trial protocols, including study objectives, endpoints, estimands, analysis populations, and key statistical considerations.
- Contribute to the development of statistical analysis plans, mock TLFs, and data review outputs that support study objectives and regulatory requirements.
- Develop, validate, and execute statistical analyses and contribute to the interpretation of study results.
- Generate, review, and interpret tables, listings, figures (TLFs), and other outputs supporting study reporting, regulatory submissions, and scientific communications.
- Support analyses of predictive, prognostic, pharmacodynamic, and other biomarker data to inform development decisions and patient selection strategies.
- Integrate and interpret clinical, biomarker, and exploratory data to support evidence generation and study decision-making.
- Ensure statistical deliverables adhere to CDISC standards (SDTM, ADaM).
- Contribute to the preparation, review, interpretation, and communication of statistical results for clinical study reports, regulatory submissions, publications, and other key scientific deliverables.
- Collaborate with clinical, data management, and programming teams throughout the study lifecycle.
Contribute to the evaluation and appropriate use of AI-assisted tools, automation, and advanced analytics approaches that enhance statistical efficiency and insight generation.
This role can be based in Cambridge (MA) or in Cambridge, UK and reports to Head of Biostatistics.
What you can expect from us
At Orion Pharma, your work impacts millions of lives around the world. With us, you get to work on challenges that matter and see the difference your work makes every day. We believe our people are the key to our success, which is why we invest in your continuous learning.
Our innovative products are world-class, and we take sustainability and ethics seriously. Rooted in our Nordic heritage, we value teamwork, low hierarchies, and a culture where every voice is heard.
We are builders of well-being and offer jobs with a clear purpose: helping people live their lives to the fullest.
Please visit our website to find further information about our values and Orion as an employer: https://www.orionpharma.com/careers/working-with-us/
What are we looking for?
- PhD or MS in Statistics, Biostatistics, or related field.
- MS with approximately 4–8 years, or PhD with 2–5 years, of relevant experience in clinical development.
- Experience supporting oncology clinical trials across multiple phases of development, including late-stage studies, is desirable.
- Strong understanding of statistical methods and their application in drug development.
- Proficiency in SAS (required); working knowledge of R.
- Demonstrated interest in applying AI-enabled approaches to improve statistical workflows, data analysis efficiency, visualization, and decision support.
How to apply
Please send your application with the latest CV and cover letter by July 26th, 2026.
The expected annual salary range for this position is USD 100,000–180,000 for U.S.-based candidates, depending on skills, experience, and job-related qualifications. For UK-based candidates, compensation will be aligned with Orion’s salary range for the applicable grade.
We typically review applications already during the application period and may start interviewing candidates before the application deadline. Therefore, we invite you to send your application as soon as possible.
#LI-ORION
Orion’s pharmaceutical innovations are created within its R&D organization. We employ over 400 top professionals in the field of drug discovery and development. We work globally: in Espoo and Turku in Finland, in Nottingham and Cambridge in the UK, and in Cambridge, MA, USA. Orion R&D and the Innovative Medicines business division are dedicated to making a transformation to become a global player in the pain and oncology therapy areas.
About UsOrion Pharma is a globally operating Nordic pharmaceutical company – a builder of well-being for over a hundred years.
We’re home to more than 4,000 Orionees around the world, and we’re proud to be known as a responsible employer and a great place to work. At Orion Pharma, people are truly valued and trusted, encouraged to grow, and supported by a culture where every voice is heard. We appreciate each other, strive for excellence, and build the future.
Together we develop, manufacture, and market human and veterinary pharmaceuticals and active pharmaceutical ingredients. Our extensive portfolio includes proprietary and generic medicines as well as consumer health products. The core therapy areas of our pharmaceutical R&D are oncology and pain. Proprietary products developed by Orion Pharma are used to treat cancer, neurological diseases, respiratory diseases, and more.
We offer careers with a clear purpose: empowering people to live their lives to the fullest.
About Orion
Similar Jobs
What you need to know about the Boston Tech Scene
Key Facts About Boston Tech
- Number of Tech Workers: 269,000; 9.4% of overall workforce (2024 CompTIA survey)
- Major Tech Employers: Thermo Fisher Scientific, Toast, Klaviyo, HubSpot, DraftKings
- Key Industries: Artificial intelligence, biotechnology, robotics, software, aerospace
- Funding Landscape: $15.7 billion in venture capital funding in 2024 (Pitchbook)
- Notable Investors: Summit Partners, Volition Capital, Bain Capital Ventures, MassVentures, Highland Capital Partners
- Research Centers and Universities: MIT, Harvard University, Boston College, Tufts University, Boston University, Northeastern University, Smithsonian Astrophysical Observatory, National Bureau of Economic Research, Broad Institute, Lowell Center for Space Science & Technology, National Emerging Infectious Diseases Laboratories



